| Registry | NCT05314270 |
|---|---|
| Status | Unknown |
| Study type | Observational |
| Enrollment | 100 (Estimated) |
| Sponsor | Assiut University (Other) |
| Conditions | Non-B Non-C Liver Cirrhosis |
| Interventions | Diagnostic tests (Diagnostic test) |
| Dates | start 2022-10-01 (estimated), primary completion 2023-10-01 (estimated), completion 2023-11-01 (estimated), first posted 2022-04-06, last updated 2022-04-06 |
Related Papers Related Patents Related Grants Related Experts
All trials for Non-B Non-C Liver Cirrhosis All trials of Diagnostic tests
To study the etiologies of patients diagnosed as non-B, non-C liver cirrhosis (NBNC-LC).
To describe the different patient's outcomes.
Liver cirrhosis is the ultimate fate of many hepatic insults that may be viral, immunologic, and metabolic or even cryptogenic. (Tsochatzis EA et al., 2014)
Recently, Non-Alcoholic Fatty Liver Disease (NAFLD) present a serious health burden worldwide that affects around 25% of the global adult population with a prevalence of around 31.8% in the Middle East. (Younossi ZM, et al., 2019)
Most of Egyptian patients presented with end-stage liver disease are secondary to post-hepatitic cirrhosis is estimated to be more than 80% of cases. (Guerra J et al., 2012)
The real profile of non-B, non-C etiologies of liver cirrhosis, in Egyptian patients, is still not fully evaluated.
Sex: All
Inclusion Criteria: * All pateints diagnosed as Non-B Non-C Liver Cirrhosis in the period from 2017_2023 Exclusion Criteria: * We will exclude the pateints that will be diagnosed as HBV-HCV induced Liver Cirrosis